Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.77 |
| ▸ | HPGD | P15428 | 4/20 | 0.77 |
| ▸ | MEN1 | O00255 | 4/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.77 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.77 |
| ▸ | GAA | P10253 | 6/20 | 0.68 |
| ▸ | LMNA | P02545 | 5/20 | 0.68 |
| ▸ | SLC5A1 | P13866 | 5/20 | 0.68 |
| ▸ | SLC5A2 | P31639 | 5/20 | 0.68 |
| ▸ | ESR1 | P03372 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.68 |
| ▸ | TTR | P02766 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15040779 | 0.88 | MAPT (0.61) | MAPTHPGDMEN1KMT2ACYP3A4 | |
| SCHEMBL13991130 | 0.88 | LMNA (0.79) | MAPTHPGDMEN1KMT2ACYP3A4 | |
| SCHEMBL5622899 | 0.88 | MAPT (0.71) | MAPTHPGDMEN1KMT2ACYP3A4 | |
| SCHEMBL11627675 | 0.87 | SLC5A1 (0.71) | MAPTHPGDMEN1KMT2ACYP3A4 | |
| SCHEMBL11628971 | 0.87 | SLC5A1 (0.71) | MAPTHPGDMEN1KMT2ACYP3A4 | |
| SCHEMBL145265 | 0.86 | LMNA (0.78) | MAPTHPGDMEN1KMT2ACYP3A4 | |
| SCHEMBL24841623 | 0.85 | CYP19A1 (0.70) | MAPTHPGDMEN1KMT2ACYP3A4 | |
| SCHEMBL6396380 | 0.84 | MAPT (0.56) | MAPTHPGDMEN1KMT2ACYP3A4 | |
| SCHEMBL1224101 | 0.83 | SLC5A1 (0.75) | MAPTHPGDMEN1KMT2ACYP3A4 | |
| Phloretin SCHEMBL38131 | 0.81 | SLC5A1 (1.00) | MAPTHPGDMEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084049-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2025-03-13 | — | — | US | disclosed |
| WO-2023278394-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2023-01-05 | — | — | WO | disclosed |
| US-9388273-B2 | Multifunctional deoxybenzoin-based monomers and resins having reduced flammability | UNIVERSITY OF MASSACHUSETTS (US) | 2016-07-12 | — | — | US | disclosed |
| US-9388273-B2 | Multifunctional deoxybenzoin-based monomers and resins having reduced flammability | UNIVERSITY OF MASSACHUSETTS (US) | 2016-07-12 | — | — | US | disclosed |
| US-9388273-B2 | Multifunctional deoxybenzoin-based monomers and resins having reduced flammability | UNIVERSITY OF MASSACHUSETTS (US) | 2016-07-12 | — | — | US | disclosed |
| US-9388273-B2 | Multifunctional deoxybenzoin-based monomers and resins having reduced flammability | UNIVERSITY OF MASSACHUSETTS (US) | 2016-07-12 | — | — | US | disclosed |
| WO-2016073947-A1 | ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | Kineta, Inc. (US) | 2016-05-12 | — | — | WO | disclosed |
| US-20160122312-A1 | ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | Kineta, Inc. | 2016-05-05 | — | — | US | disclosed |
| US-20160122312-A1 | ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | Kineta, Inc. | 2016-05-05 | — | — | US | disclosed |
| WO-2015009812-A2 | ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | Kineta, Inc. (US) | 2015-01-22 | — | — | WO | disclosed |
| US-20140357829-A1 | MULTIFUNCTIONAL DEOXYBENZOIN-BASED MONOMERS AND RESINS HAVING REDUCED FLAMMABILITY | UNIVERSITY OF MASSACHUSETTS | 2014-12-04 | — | — | US | disclosed |
| US-20140357829-A1 | MULTIFUNCTIONAL DEOXYBENZOIN-BASED MONOMERS AND RESINS HAVING REDUCED FLAMMABILITY | UNIVERSITY OF MASSACHUSETTS | 2014-12-04 | — | — | US | disclosed |
| US-20140357829-A1 | MULTIFUNCTIONAL DEOXYBENZOIN-BASED MONOMERS AND RESINS HAVING REDUCED FLAMMABILITY | UNIVERSITY OF MASSACHUSETTS | 2014-12-04 | — | — | US | disclosed |
| US-20090062555-A1 | Synthesis of Isoflavone | BAUSCH & LOMB INCORPORATED | 2009-03-05 | — | — | US | disclosed |
| US-20090062555-A1 | Synthesis of Isoflavone | BAUSCH & LOMB INCORPORATED | 2009-03-05 | — | — | US | disclosed |
| US-7326797-B2 | Manufacture of isoflavones | DSM IP ASSETS B.V. (NL) | 2008-02-05 | — | — | US | disclosed |
| EP-1523478-B1 | MANUFACTURE OF ISOFLAVONES | DSM IP ASSETS BV (NL) | 2007-12-12 | — | — | EP | disclosed |
| US-20050256321-A1 | Manufacture of isoflavones | DSM IP ASSETS B.V. (NL) | 2005-11-17 | — | — | US | disclosed |
| EP-1523478-A2 | MANUFACTURE OF ISOFLAVONES | DSM IP Assets B.V. (NL) | 2005-04-20 | — | — | EP | disclosed |
| WO-2004009576-A2 | MANUFACTURE OF ISOFLAVONES | DSM IP ASSETS B.V. (NL) | 2004-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062555-A1 | Synthesis of Isoflavone | HSD17B7, F3, AKR1C3 | MAPT 4338/4885HPGD 767/4885MEN1 1185/4885 |
| US-20250084049-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | PGC, SLC5A6, PUF60 | MAPT 3007/4885HPGD 1526/4885MEN1 2672/4885 |
| US-20160122312-A1 | ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | MAVS, EIF2AK2, IRF3 | MAPT 3846/4885HPGD 3295/4885MEN1 4806/4885 |
| US-20140357829-A1 | MULTIFUNCTIONAL DEOXYBENZOIN-BASED MONOMERS AND RESINS HAVING REDUCED FLAMMABILITY | FLAD1, MMAB, FLNB | MAPT 3054/4885HPGD 391/4885MEN1 4182/4885 |
| US-20050256321-A1 | Manufacture of isoflavones | HAAO, HAO2, CYP2F1 | MAPT 4700/4885HPGD 71/4885MEN1 3253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.